C 12 H11N5, monoclinic, P21/n (no. 14), a = 7.3455 (1) 
WinGX and ORTEP [4] restraint of N-H = 0.88 ± 0.01 Å, and with unconstrained U iso (H).
Discussion
The 5-aza-7-deaza-isostere (imidazo[1,2-a][1, 3, 5]triazine) of the purine system is an important scaffold for the construction of various drugs. Such compounds have been developed as inhibitors for enzymes, e.g. focal adhesion kinase [6] . Further, these compounds display anti-viral activity [7] , are agonists of opioid m-receptors [8] and function as ligands for adenosine receptors [9] . A hindrance to the embellishment of this class of compound has been the difficulty in their synthesis. Very recently, a new procedure for the synthesis of 5-aza-7-deaza-isosteres was developed, i.e. through the reaction of 2-aminoimidazoles, triethylorthoformate and cyanamide under microwave irradiation [5] . The title compound was one of the new compounds synthesised in the course of that study. The title molecule is shown in the figure (70% displacement ellipsoids) and comprises a six-and five-membered fused ring system connected to the 4-methylphenyl group at C4. The r.m.s. deviation of the nine atoms of the imidazotriazine group is 0.0218 Å with the maximum deviations being 0.0399(7) Å for the C2 atom and to the other side of the leastsquares plane, 0.0273(7) Å for the C3 atom. The amino-N5 atom lies 0.1258(13) Å out of the plane in the direction of the C2 atom. There is a twist between this plane and that through the appended 4-methylphenyl group as seen in the dihedral angle of 12.39(4)°formed between them. The overall molecular geometry resembles that reported for the 4-methoxyphenyl derivative [5] . 
